Resmed

Index
Globenewswire

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Globenewswire

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Globenewswire

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

Globenewswire

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Globenewswire

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Globenewswire

Resmed Acquires VirtuOx

Globenewswire

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Globenewswire

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Globenewswire

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Globenewswire

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Globenewswire

Vaping Expected to Increase COPD Health and Economic Burden by 2050

Globenewswire

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

Globenewswire

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

Globenewswire

ResMed Adopts New Operating Model to Accelerate Long-term Growth

Globenewswire

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software